{"text": ["AbbVie Announces Late-Breaking Results from Phase 3 Trial of HUMIRA\u00ae (adalimumab) in Hidradenitis Suppurativa (HS) Patients at the European Dermatology and Venereology Congress"], "created_at": "Mon, 13 Oct 2014 07:00:00 GMT"}
